LTRN Annual CFO
-$14.35 M
-$1.58 M-12.37%
31 December 2023
Summary:
As of January 23, 2025, LTRN annual cash flow from operations is -$14.35 million, with the most recent change of -$1.58 million (-12.37%) on December 31, 2023. During the last 3 years, it has fallen by -$8.69 million (-153.85%). LTRN annual CFO is now -1028.31% below its all-time high of -$1.27 million, reached on December 31, 2018.LTRN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN Quarterly CFO
-$5.58 M
-$391.70 K-7.55%
30 September 2024
Summary:
As of January 23, 2025, LTRN quarterly cash flow from operations is -$5.58 million, with the most recent change of -$391.70 thousand (-7.55%) on September 30, 2024. Over the past year, it has dropped by -$1.97 million (-54.54%). LTRN quarterly CFO is now -1211.63% below its all-time high of -$425.60 thousand, reached on March 31, 2019.LTRN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN TTM CFO
-$17.23 M
-$1.97 M-12.91%
30 September 2024
Summary:
As of January 23, 2025, LTRN TTM cash flow from operations is -$17.23 million, with the most recent change of -$1.97 million (-12.91%) on September 30, 2024. Over the past year, it has dropped by -$3.60 million (-26.39%). LTRN TTM CFO is now -3947.63% below its all-time high of -$425.60 thousand, reached on March 31, 2019.LTRN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LTRN Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -12.4% | -54.5% | -26.4% |
3 y3 years | -153.8% | -19.2% | -70.2% |
5 y5 years | -1028.3% | -915.1% | -709.6% |
LTRN Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -35.5% | at low | -173.8% | at low | -62.6% | at low |
5 y | 5-year | -574.2% | at low | -1037.2% | at low | -709.6% | at low |
alltime | all time | -1028.3% | at low | -1211.6% | at low | -3947.6% | at low |
Lantern Pharma Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.58 M(+7.5%) | -$17.23 M(+12.9%) |
June 2024 | - | -$5.19 M(+69.2%) | -$15.26 M(+11.7%) |
Mar 2024 | - | -$3.07 M(-9.4%) | -$13.66 M(-4.8%) |
Dec 2023 | -$14.35 M(+12.4%) | -$3.39 M(-6.3%) | -$14.35 M(+5.3%) |
Sept 2023 | - | -$3.61 M(+0.6%) | -$13.63 M(-3.0%) |
June 2023 | - | -$3.59 M(-4.4%) | -$14.06 M(+6.5%) |
Mar 2023 | - | -$3.76 M(+40.8%) | -$13.20 M(+3.4%) |
Dec 2022 | -$12.77 M(+20.5%) | -$2.67 M(-33.9%) | -$12.77 M(+5.2%) |
Sept 2022 | - | -$4.04 M(+47.8%) | -$12.14 M(-5.0%) |
June 2022 | - | -$2.73 M(-17.9%) | -$12.78 M(+8.6%) |
Mar 2022 | - | -$3.33 M(+63.2%) | -$11.77 M(+11.2%) |
Dec 2021 | -$10.59 M | -$2.04 M(-56.5%) | -$10.59 M(+4.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | -$4.68 M(+171.4%) | -$10.12 M(+21.5%) |
June 2021 | - | -$1.73 M(-19.5%) | -$8.33 M(+17.4%) |
Mar 2021 | - | -$2.14 M(+36.8%) | -$7.09 M(+25.5%) |
Dec 2020 | -$5.65 M(+165.6%) | -$1.57 M(-45.7%) | -$5.65 M(+17.9%) |
Sept 2020 | - | -$2.89 M(+488.6%) | -$4.79 M(+95.4%) |
June 2020 | - | -$490.90 K(-30.2%) | -$2.45 M(+2.0%) |
Mar 2020 | - | -$703.00 K(-0.8%) | -$2.41 M(+13.0%) |
Dec 2019 | -$2.13 M(+67.4%) | -$708.90 K(+28.9%) | -$2.13 M(+50.0%) |
Sept 2019 | - | -$549.90 K(+24.0%) | -$1.42 M(+63.3%) |
June 2019 | - | -$443.50 K(+4.2%) | -$869.10 K(+104.2%) |
Mar 2019 | - | -$425.60 K | -$425.60 K |
Dec 2018 | -$1.27 M | - | - |
FAQ
- What is Lantern Pharma annual cash flow from operations?
- What is the all time high annual CFO for Lantern Pharma?
- What is Lantern Pharma annual CFO year-on-year change?
- What is Lantern Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lantern Pharma?
- What is Lantern Pharma quarterly CFO year-on-year change?
- What is Lantern Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Lantern Pharma?
- What is Lantern Pharma TTM CFO year-on-year change?
What is Lantern Pharma annual cash flow from operations?
The current annual CFO of LTRN is -$14.35 M
What is the all time high annual CFO for Lantern Pharma?
Lantern Pharma all-time high annual cash flow from operations is -$1.27 M
What is Lantern Pharma annual CFO year-on-year change?
Over the past year, LTRN annual cash flow from operations has changed by -$1.58 M (-12.37%)
What is Lantern Pharma quarterly cash flow from operations?
The current quarterly CFO of LTRN is -$5.58 M
What is the all time high quarterly CFO for Lantern Pharma?
Lantern Pharma all-time high quarterly cash flow from operations is -$425.60 K
What is Lantern Pharma quarterly CFO year-on-year change?
Over the past year, LTRN quarterly cash flow from operations has changed by -$1.97 M (-54.54%)
What is Lantern Pharma TTM cash flow from operations?
The current TTM CFO of LTRN is -$17.23 M
What is the all time high TTM CFO for Lantern Pharma?
Lantern Pharma all-time high TTM cash flow from operations is -$425.60 K
What is Lantern Pharma TTM CFO year-on-year change?
Over the past year, LTRN TTM cash flow from operations has changed by -$3.60 M (-26.39%)